<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=7238636&amp;fmt=gif">

THERAPY AREAS

Clinical Development Expertise Across Key Therapeutic Areas

Successful clinical development requires more than operational execution—it requires therapeutic insight.

Book A Consultation Get A Demo
stockphotoscom-8601555
950+
total studies
600+
Ophthalmology studies
100+
Cancer studies
50+
Neurological/CNS disorder studies

Therapy Types and Therapeutic Areas We Support

Our experience spans over 800+ drug and biologic programs and more than 130 device and diagnostics studies among our 950+ trials.   These include studies for regenerative medicine, rare and genetic diseases, pediatric populations, and vaccines.   We provide sponsors with a broad depth of therapy area expertise to navigate complex clinical and regulatory pathways with confidence.

Our top 3 therapeutic areas of expertise include:

 

While our recent experience has been heavily concentrated in ophthalmology, oncology, and neurology/CNS, our multidisciplinary teams bring deep expertise across a broad range of therapeutic areas, enabling us to support complex development programs from early-phase studies through regulatory submission and commercialization.

  • Cardiovascular Disease
  • Dermatology
  • Dental/Oral Health
  • Endocrinology
  • Gastroenterology
  • Hematology
  • Infectious Disease
  • Musculoskeletal
  • Nephrology
  • Rare Disease
  • Respiratory
  • Rheumatology
  • and more
While our recent experience has been heavily concentrated in ophthalmology, oncology, and neurology/CNS, our multidisciplinary teams bring deep expertise across a broad range of therapeutic areas, enabling us to support complex development programs from early-phase studies through regulatory submission and commercialization. Cardiovascular Disease Dermatology Dental/Oral Health Endocrinology Gastroenterology Hematology Infectious Disease Musculoskeletal Nephrology Rare Disease Respiratory Rheumatology and more

Ophthalmology Expertise Across the Development Lifecycle

With experience supporting 600+ ophthalmology studies, SDC helps sponsors design, manage, analyze, and submit ophthalmic clinical programs from Phase 1 through regulatory approval. Our team has also helped shape industry standards, including support for ophthalmology CDISC development.

TA_Ohpthalmology_-5109103-1

Key Experience

  • 600+ ophthalmology studies supported
  • 20+ product approvals
  • Device, diagnostic, and drug development expertise
  • Adaptive trial design and pooled analysis capabilities
  • Regulatory submission support
Key Experience

Ophthalmology indications include:

Retinal Disorders
  • AMD
  • DME
  • RVO
Geographic Atrophy
Glaucoma & Ocular Hypertension
Corneal & Ocular Surface Disease
  • Dry Eye
  • Keratitis
  • Corneal Disorders
Inflammatory Conditions
  • Anterior/Posterior Chamber Inflammation
  • Post-Operative Inflammation
Rare Ophthalmic Diseases, and more...
Ophthalmology indications include:

Oncology Expertise Across the Development Lifecycle

Supporting the Next Generation of Cancer Therapies
SDC provides oncology expertise across a broad range of tumor types and study designs, supporting programs from early-phase development through global Phase 3 trials and regulatory interactions.

TA_Oncology_1_13423521-1

Key Experience

  • 100+ oncology studies supported
  • Early-phase through global Phase 3 experience
  • Adaptive and Bayesian trial designs
  • Global regulatory expertise with 10+ cancer submissions supported
Key Experience

Cancer indications include:

Solid Tumors

  • Brain
  • Breast
  • Head & Neck
  • Lung
  • Gastrointestinal
  • Genitourinary
  • Prostate
Hematologic Malignancies
  • Leukemias
  • Lymphomas
  • Multiple Myeloma (MM)
Rare & Precision Oncology and more...
Cancer indications include:

Neurology & CNS Expertise Across the Development Lifecycle

SDC supports pharmaceutical, diagnostic, and medical device studies across a variety of neurological conditions. Our experienced teams provide full-service support from early-phase development through pivotal trials and regulatory submission.

TA_CNS_2_5839114-1

Key Experience

  • 50+ CNS/Neurodegenerative disease studies supported
  • Pharmaceutical, device, and diagnostic expertise
  • Early-phase through pivotal studies
  • PK, MAD, and complex study designs
  • Full-service clinical development support
Key Experience

Neurological Diseases and CNS indications:

Neurodegenerative Disorders
  • Alzheimer's Disease
  • Parkinson's Disease
  • ALS
Movement Disorders
Neurodevelopmental Disorders
Neuromuscular Disorders
Epilepsy & Seizure Disorders
Rare Neurological Diseases
CNS Diagnostics & Devices, and more...
Neurological Diseases and CNS indications:

Bring Proven Therapeutic Expertise to Your Next Study

Whether you're advancing a first-in-human program or preparing for regulatory submission, SDC provides the therapeutic insight, technology-enabled solutions, and operational expertise needed to accelerate development and empower better clinical decisions.